Cancer medications granted accelerated approval are often confirmed despite not demonstrating a benefit in overall survival or quality of life.

by Eric Fitzsimmons

More cancer patients are enrolling in clinical trials, and sentinel node biopsies alone may be adequate for some early-stage breast cancers.

by Marci A. Landsmann

New recommendations clarify when women diagnosed with breast cancer should be offered genetic testing for inherited cancer risk.

by Laura Gesualdi-Gilmore

Survival rates have increased for older AML patients who receive stem cell transplants, and cervical cancer diagnoses rise among women living in low-income counties.

by Kevin McLaughlin

The recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.

by Sandra Gordon

First CAR T-cell therapy approval in chronic lymphocytic leukemia, and Environmental Protection Agency announces a complete ban on asbestos use in manufacturing.

by Thomas Celona

Patients have been entitled to immediate access to medical records and test results for three years as a result of the Cures Act. It has changed how patients and doctors share information.

by Taneia Surles

Modified CAR T-cell therapy shows promise in glioblastoma, and an immunotherapy may soon be available as an injection.

by Eric Fitzsimmons

After twice being treated for leukemia as a child, Brady Lucas discusses the mental impact of pediatric cancer.

by Suzanne McBride

Why do many Asian American women who have never smoked have lung cancer, and a report finds acne products can create cancer-causing benzine.

by Marci A. Landsmann